Target specific optimization of cationic lipid-based systems for pulmonary gene therapy
D Deshpande1, P Blezinger, R Pillai
1GENEMEDICINE, INC., The Woodlands, Texas 77381-4248, USA. deshpd@genemedicine.com
Pharmaceutical Research
|October 2, 1998
Summary
Formulation variables significantly impact cationic lipid-mediated gene delivery to the lungs. Optimizing lipid structure, DNA ratio, particle size, and plasmid topology enhances transgene expression and DNA stability in pulmonary tissues.
Area of Science:
- Gene Therapy
- Nanotechnology in Medicine
- Pulmonary Drug Delivery
Background:
- Cationic lipids are effective in delivering foreign genes to the pulmonary epithelium in vivo.
- Gene delivery efficiency is influenced by factors beyond just lipid molecular structure.
Purpose of the Study:
- To evaluate the impact of formulation variables on transgene expression in the lung.
- Investigate the effects of cationic lipid structure, lipid/DNA ratio, particle size, co-lipid content, and plasmid topology.
Main Methods:
- Cationic lipid-based gene delivery systems were formulated with varying surface and colloidal properties.
- Systems were administered to rats via intratracheal instillation.
- Transgene expression was measured using an expression plasmid encoding chloramphenicol acetyl transferase (CAT).
Main Results:
- Cationic lipid structure, lipid/DNA ratio, particle size, co-lipid content, and plasmid topology significantly influenced transgene expression.
- Lipid complexation protected DNA integrity in bronchoalveolar lavage fluid (BALF).
- Quantitative PCR confirmed enhanced persistence of lipid-complexed DNA in rat lungs.
Conclusions:
- Instilled formulations successfully reached the lower airways and alveolar regions.
- Cationic lipid-mediated gene expression is predominantly localized within the lung parenchyma.
- Gene expression was not observed in cells isolated from BALF, suggesting targeted delivery.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


